Cargando…
Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
Coronaviruses SARS-CoV-2 infected more than 156 million people and caused over 3 million death in the whole world, therefore a better understanding of the underlying pathogenic mechanism and the searching for more effective treatments were urgently needed. Angiotensin-converting enzyme 2 (ACE2) was...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639591/ https://www.ncbi.nlm.nih.gov/pubmed/34867400 http://dx.doi.org/10.3389/fphar.2021.771555 |
_version_ | 1784609182784159744 |
---|---|
author | Yan, Meichen Dong, Yuan Bo, Xuena Cheng, Yong Cheng, Jinbo |
author_facet | Yan, Meichen Dong, Yuan Bo, Xuena Cheng, Yong Cheng, Jinbo |
author_sort | Yan, Meichen |
collection | PubMed |
description | Coronaviruses SARS-CoV-2 infected more than 156 million people and caused over 3 million death in the whole world, therefore a better understanding of the underlying pathogenic mechanism and the searching for more effective treatments were urgently needed. Angiotensin-converting enzyme 2 (ACE2) was the receptor for SARS-CoV-2 infection. In this study, we found that ACE2 was an interferon-stimulated gene (ISG) in human cell lines. By performing an ISG library screening, we found that ACE2 levels were positively regulated by multiple ISGs. Interestingly, ACE2 levels were highly correlated with ISGs-induced NF-κB activities, but not IFNβ levels. Furthermore, using an approved clinical durgs library, we found two clinical drugs, Cepharanthine and Glucosamine, significantly inhibited ACE2 level, IFNβ level, and NF-κB signaling downstream TNFα and IL6 levels. Our finding suggested the possible inhibitory effects of Cepharanthine and Glucosamine during SARS-CoV-2 infection and the subsequent inflammatory cytokine storm. |
format | Online Article Text |
id | pubmed-8639591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86395912021-12-04 Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels Yan, Meichen Dong, Yuan Bo, Xuena Cheng, Yong Cheng, Jinbo Front Pharmacol Pharmacology Coronaviruses SARS-CoV-2 infected more than 156 million people and caused over 3 million death in the whole world, therefore a better understanding of the underlying pathogenic mechanism and the searching for more effective treatments were urgently needed. Angiotensin-converting enzyme 2 (ACE2) was the receptor for SARS-CoV-2 infection. In this study, we found that ACE2 was an interferon-stimulated gene (ISG) in human cell lines. By performing an ISG library screening, we found that ACE2 levels were positively regulated by multiple ISGs. Interestingly, ACE2 levels were highly correlated with ISGs-induced NF-κB activities, but not IFNβ levels. Furthermore, using an approved clinical durgs library, we found two clinical drugs, Cepharanthine and Glucosamine, significantly inhibited ACE2 level, IFNβ level, and NF-κB signaling downstream TNFα and IL6 levels. Our finding suggested the possible inhibitory effects of Cepharanthine and Glucosamine during SARS-CoV-2 infection and the subsequent inflammatory cytokine storm. Frontiers Media S.A. 2021-11-19 /pmc/articles/PMC8639591/ /pubmed/34867400 http://dx.doi.org/10.3389/fphar.2021.771555 Text en Copyright © 2021 Yan, Dong, Bo, Cheng and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yan, Meichen Dong, Yuan Bo, Xuena Cheng, Yong Cheng, Jinbo Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title | Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title_full | Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title_fullStr | Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title_full_unstemmed | Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title_short | Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels |
title_sort | large screening identifies ace2 positively correlates with nf-κb signaling activity and targeting nf-κb signaling drugs suppress ace2 levels |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639591/ https://www.ncbi.nlm.nih.gov/pubmed/34867400 http://dx.doi.org/10.3389/fphar.2021.771555 |
work_keys_str_mv | AT yanmeichen largescreeningidentifiesace2positivelycorrelateswithnfkbsignalingactivityandtargetingnfkbsignalingdrugssuppressace2levels AT dongyuan largescreeningidentifiesace2positivelycorrelateswithnfkbsignalingactivityandtargetingnfkbsignalingdrugssuppressace2levels AT boxuena largescreeningidentifiesace2positivelycorrelateswithnfkbsignalingactivityandtargetingnfkbsignalingdrugssuppressace2levels AT chengyong largescreeningidentifiesace2positivelycorrelateswithnfkbsignalingactivityandtargetingnfkbsignalingdrugssuppressace2levels AT chengjinbo largescreeningidentifiesace2positivelycorrelateswithnfkbsignalingactivityandtargetingnfkbsignalingdrugssuppressace2levels |